{"slug":"olix-pharmaceuticals","name":"올릭스","name_en":"OliX Pharmaceuticals","ticker":"226950.KQ","updated_at":"2026-07-11T10:22:21.017+00:00","canonical":"https://valuechain.wiki/olix-pharmaceuticals","kicker":"코스닥 대형주","kicker_en":"KOSDAQ large cap","lead":"RNA간섭 기반 신약을 개발하는 바이오기업으로, 비대흉터와 안질환·대사질환 치료 후보물질을 보유하고 있다. 코스닥 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A biotech developing RNA-interference drugs, with candidates for hypertrophic scars, eye diseases and metabolic disorders. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"신약개발(RNAi)"},{"name":"화장품(자회사)"}]},"segments_en":{"parts":[{"name":"Drug development (RNAi)"},{"name":"Cosmetics (subsidiary)"}]},"returns_yearly":{"2021":-40.5,"2022":-26,"2023":-29.9,"2024":8.9,"2025":746,"2026":-10.7},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}